Alan H. Fairlamb
Dow Street, DD1 5EH
Dundee, SCT, United Kingdom
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Comparative metabolism of conjugated and unconjugated pterins in Crithidia, Leishmania and African trypanosomes.
Journal: PLoS neglected tropical diseases
Published: May 05, 2025
Validation of Trypanosoma cruzi inactivation techniques for laboratory use.
Journal: PloS one
Published: December 22, 2023
The critical role of mode of action studies in kinetoplastid drug discovery.
Journal: Frontiers in drug discovery
Published: August 21, 2023
Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.
Journal: Nature
Published: July 04, 2023
Tres Cantos Open Lab: celebrating a decade of innovation in collaboration to combat endemic infectious diseases.
Journal: Nature reviews. Drug discovery
Published: September 02, 2021
Surmounting structural barriers to tackle endemic infectious diseases.
Journal: The Journal of experimental medicine
Published: August 19, 2021
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity.
Journal: ACS medicinal chemistry letters
Published: April 06, 2021
Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties.
Journal: European journal of medicinal chemistry
Published: May 28, 2020
Discovery of an Allosteric Binding Site in Kinetoplastid Methionyl-tRNA Synthetase.
Journal: ACS infectious diseases
Published: April 11, 2020
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi.
Journal: European journal of medicinal chemistry
Published: March 17, 2020
Last Updated: 09/26/2026